Back to top

Infinity Pharmaceuticals, Inc. (INFI) in Focus: Stock Moves 12% Higher
October 09, 2017

Read MoreHide Full Article

Infinity Pharmaceuticals, Inc. (INFI - Free Report) was a big mover last session, as the company saw its shares rise nearly 12% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $1.14–$1.33 in the past one-month time frame, witnessed a sharp increase yesterday.

The company has seen no estimate revisions over the past one month, and the Zacks Consensus Estimate for the current quarter has also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Infinity Pharmaceuticals currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.

Infinity Pharmaceuticals, Inc. Price and Consensus

A better-ranked stock in the Medical - Drugs industry is Corbus Pharmaceuticals Holdings, Inc. (CRBP - Free Report) which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Is INFI going up? Or down? Predict to see what others think: Up or Down

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

See the pot trades we're targeting>>




In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Infinity Pharmaceuticals, Inc. (INFI) - free report >>

Corbus Pharmaceuticals Holdings, Inc. (CRBP) - free report >>


More from Zacks Tale of the Tape

You May Like